CABENUVA (cabotegravir injectable suspension)
CABENUVA (cabotegravir extended-release injectable suspension)
INDICATIONS AND USAGE
CABENUVA, a 2-drug co-packaged product of cabotegravir, a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), is indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
DOSAGE FORMS & STRENGTHS: Cabotegravir extended-release injectable suspension and rilpivirine extendedrelease injectable suspension, co-packaged as follows:
CABENUVA 400-mg/600-mg Kit:
• single-dose vial of 400 mg/2 mL (200 mg/mL) cabotegravir
• single-dose vial of 600 mg/2 mL (300 mg/mL) rilpivirine CABENUVA 600-mg/900-mg Kit:
• single-dose vial of 600 mg/3 mL (200 mg/mL) cabotegravir
Manufactured By: ViiV Healthcare
Prescribing Information URL: Click Here
HOW TO MAKE AN ENQUIRY FOR CABENUVA (cabotegravir injectable suspension)?
FDA approved Anti-Cancer medicine CABENUVA (cabotegravir injectable suspension) is available upon request. To get best retail price of CABENUVA (cabotegravir injectable suspension) in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email email@example.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with HIV specialist.